Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wildtype (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT

Category Primary study
JournalJournal of Clinical Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 244cc3a96283da283b31d46dac5803d0a9793304
First added on: Feb 07, 2025